CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $96.42M, above the global median of $18.73M
- FinancialsAltman Z-Score 2.43: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.25%Below 5Y avg (0.48%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
18.5%Sustainable
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.98BCNY1.04B · vs all stocks (USD)
Trailing P/E
74.26xRevenue (TTM)
3.30BCNY491.84M · vs all stocks (USD)
Profit Margin
2.75%Beta
0.2530xvs all stocks
52-Week Change
-23.06%vs all stocks
Market Capitalization
6.98BCNY1.04B · vs all stocks (USD)
Enterprise Value
8.23BCNY1.23B · vs all stocks (USD)
Trailing P/E
74.26xForward P/E
31.83xPrice to Sales (TTM)
2.12xPrice to Book (MRQ)
1.94xEnterprise to Revenue
2.50xEnterprise to EBITDA
15.16xGross Margin
28.58%Profit Margin
2.75%Operating Margin
6.33%Return on Assets (TTM)
1.68%Return on Equity (TTM)
2.37%Revenue (TTM)
3.30BCNY491.84M · vs all stocks (USD)
Revenue per Share (TTM)
9.70CNYUpdated Sep 21, 2026Quarterly Revenue Growth
18.00%Gross Profit (TTM)
1.07BCNY159.17M · vs all stocks (USD)
EBITDA (TTM)
653.10MCNY97.46M · vs all stocks (USD)
Net Income (TTM)
90.54MCNY13.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-7.70%Operating Cash Flow (TTM)
898.14MCNY134.02M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
646.14MCNY96.42M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.25%vs all stocks
5-Year Average Dividend Yield
0.48%vs all stocks
Payout Ratio
18.52%Revenue
3.06BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.93BCNYFY2025 · Dec 31, 2025Gross Profit
1.14BCNYFY2025 · Dec 31, 2025Operating Income
304.40MCNY45.42M · vs all stocks (USD)
Pre-tax Income
158.60MCNYFY2025 · Dec 31, 2025Income Tax Expense
18.89MCNYFY2025 · Dec 31, 2025Net Income
139.71MCNYFY2025 · Dec 31, 2025EBIT
201.73MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
653.10MCNYFY2025 · Dec 31, 2025Research & Development
240.31MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
224.38MCNYFY2025 · Dec 31, 2025Other Operating Expenses
36.47MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
43.13MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
340.76MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
340.76MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
139.71MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
118.19MCNYFY2025 · Dec 31, 2025Free Cash Flow
-234.86MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
382.25MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
139.71MCNYFY2025 · Dec 31, 2025Other Non-cash Items
43.52MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-167.82MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
102.77MCNYFY2025 · Dec 31, 2025Capital Expenditures
-353.05MCNYFY2025 · Dec 31, 2025Purchase of Investments
-20.00MCNYFY2025 · Dec 31, 2025Sale of Investments
299.24KCNYFY2025 · Dec 31, 2025Other Investing Activity
2.44MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-370.31MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.12BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.18BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-57.96MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.83MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-122.03MCNYFY2025 · Dec 31, 2025Shares Outstanding
347.98MSharesUpdated Sep 21, 2026Float Shares
159.05MSharesUpdated Sep 21, 2026% Held by Insiders
53.46%vs all stocks
% Held by Institutions
13.79%vs all stocks
Total Cash (MRQ)
634.69MCNY94.71M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.84CNYUpdated Sep 21, 2026Total Debt (MRQ)
1.91BCNY284.57M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5290xCurrent Ratio (MRQ)
1.12xBook Value per Share (MRQ)
10.33CNYUpdated Sep 21, 2026Total Assets
6.59BCNY983.25M · vs all stocks (USD)
Total Current Assets
3.01BCNYFY2025 · Dec 31, 2025Total Liabilities
2.95BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.58BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
323.64MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.63BCNYFY2025 · Dec 31, 2025Cash
381.84MCNYFY2025 · Dec 31, 2025Cash Equivalents
130.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
512.25MCNYFY2025 · Dec 31, 2025Other Short-term Investments
798.90KCNYFY2025 · Dec 31, 2025Accounts Receivable
556.85MCNYFY2025 · Dec 31, 2025Inventory
1.71BCNYFY2025 · Dec 31, 2025Accounts Payable
867.35MCNYFY2025 · Dec 31, 2025Short-term Debt
1.54BCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.36MCNYFY2025 · Dec 31, 2025Long-term Debt
226.89MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
16.77MCNYFY2025 · Dec 31, 2025Common Stock (Book)
347.98MCNYFY2025 · Dec 31, 2025Retained Earnings
1.78BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.64BCNY543.10M · vs all stocks (USD)
Treasury Stock
44.69MCNYFY2025 · Dec 31, 202552-Week Low
17.98CNYUpdated Sep 21, 202652-Week High
27.80CNYUpdated Sep 21, 202652-Week Change
-23.06%vs all stocks
Beta
0.2530xvs all stocks
50-Day MA
21.20CNYUpdated Sep 21, 2026200-Day MA
22.26CNYUpdated Sep 21, 2026Avg 10-Day Volume
2.14MSharesUpdated Sep 21, 2026Avg 30-Day Volume
2.64MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.2700CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.43: grey zoneSignificant
Altman Z-Score: 2.43
Low earnings qualitySignificant
Earnings Quality Score: -3.95
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $96.42M, above the global median of $18.73MNotable
Levered free cash flow (USD): 96,416,624.022Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Aidea Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alto Neuroscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hubei Hongyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MeiraGTx Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
China Animal Husbandry Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Star Lake Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Bide Pharmatech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Kanion Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zylox-Tonbridge Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule